Mostrar el registro sencillo del ítem
dc.contributor.author
Schmid, Edward T.
dc.contributor.author
Pang, Iris K.
dc.contributor.author
Carrera Silva, Eugenio Antonio
dc.contributor.author
Bosurgi, Lidia
dc.contributor.author
Miner, Jonathan J
dc.contributor.author
Diamond, Michael S
dc.contributor.author
Iwasaki, Akiko
dc.contributor.author
Rothlin, Carla
dc.date.available
2018-07-27T18:17:29Z
dc.date.issued
2016-06
dc.identifier.citation
Schmid, Edward T.; Pang, Iris K.; Carrera Silva, Eugenio Antonio; Bosurgi, Lidia; Miner, Jonathan J; et al.; AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity; eLife Sciences Publications; eLife; 5; 6-2016; 1-18
dc.identifier.issn
2050-084X
dc.identifier.uri
http://hdl.handle.net/11336/53313
dc.description.abstract
The receptor tyrosine kinase (RTK) AXL is induced in response to type I interferons (IFNs) and limits their production through a negative feedback loop. Enhanced production of type I IFNs in Axl(-/-) dendritic cells (DCs) in vitro have led to speculation that inhibition of AXL would promote antiviral responses. Notwithstanding, type I IFNs also exert potent immunosuppressive functions. Here we demonstrate that ablation of AXL enhances the susceptibility to infection by influenza A virus and West Nile virus. The increased type I IFN response in Axl(-/-) mice was associated with diminished DC maturation, reduced production of IL-1β, and defective antiviral T cell immunity. Blockade of type I IFN receptor or administration of IL-1β to Axl(-/-) mice restored the antiviral adaptive response and control of infection. Our results demonstrate that AXL is essential for limiting the immunosuppressive effects of type I IFNs and enabling the induction of protective antiviral adaptive immunity.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
eLife Sciences Publications
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
Axl
dc.subject
Dendritic Cells
dc.subject
Antiviral Response
dc.subject
T Cell
dc.subject.classification
Inmunología
dc.subject.classification
Medicina Básica
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2018-07-17T20:50:13Z
dc.journal.volume
5
dc.journal.pagination
1-18
dc.journal.pais
Reino Unido
dc.journal.ciudad
Cambridge
dc.description.fil
Fil: Schmid, Edward T.. University of Yale; Estados Unidos
dc.description.fil
Fil: Pang, Iris K.. University of Yale; Estados Unidos
dc.description.fil
Fil: Carrera Silva, Eugenio Antonio. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. University of Yale; Estados Unidos
dc.description.fil
Fil: Bosurgi, Lidia. University of Yale; Estados Unidos
dc.description.fil
Fil: Miner, Jonathan J. Washington University School of Medicine; Estados Unidos
dc.description.fil
Fil: Diamond, Michael S. Washington University School of Medicine; Estados Unidos
dc.description.fil
Fil: Iwasaki, Akiko. University of Yale; Estados Unidos
dc.description.fil
Fil: Rothlin, Carla. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. University of Yale; Estados Unidos
dc.journal.title
eLife
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/https://dx.doi.org/10.7554/eLife.12414
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://elifesciences.org/articles/12414
Archivos asociados